Furthermore, we identified the top three factors with the greatest impact on the models: for primary ovarian cancer patients, these were BRCA mutation/HRD status, TBAs, and fibrinogen concentration, while for recurrent ovarian cancer patients, they were FBG, CA-199, and Ki67. The gene discussed is MKI67; the disease is ovarian cancer.